Biosimulation company Certara said on Thursday that the international registry of healthcare workers will collect information on risk factors for developing COVID-19 as well as using preventative therapies in protecting the healthcare workers during today's global health crisis and for future outbreaks, under The International Registry of Healthcare Workers Exposed to COVID-19 (UNITY Global).
Under UNITY Global, Certara will enable prevention policies based on real-world data collected from 10,000 healthcare workers in low- and middle- income countries. The initiative was funded by the COVID-19 Therapeutics Accelerator. The primary objective is to assess the association between the use of preventive treatments and the occurrence of SARS-CoV-2 infection in healthcare workers.
The company stated the registry first launched in Pakistan on 3 August 2020 and will enroll 10,000 healthcare workers. Additional countries preparing for launch of the registry include South Africa, Nigeria, Kenya, Uganda, Senegal, Zambia and Zimbabwe. The registry collects information on a weekly basis from enrollees across a 12-week period. The registry will record SARS-CoV-2 antibody test results.
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government
Fusion Antibodies secures multi-target humanisation contract with global pharmaceutical client
Genmab to acquire Merus in USD8bn deal to strengthen oncology pipeline
Wolters Kluwer launches UpToDate Expert AI to deliver trusted GenAI clinical decision support
CVS Health declares unchanged quarterly dividend
ALK partners with GenSci to expand allergy immunotherapy market in China
Curatis secures Swiss distribution deal with Phoenix Labs
Innocan Pharma reports 'positive swing' in operating profitability for first half of 2025
Wolters Kluwer boosts medical research efficiency with Ovid AI summarisation